Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sterile purified water is utilized as an intravesical placebo control in clinical research, specifically in a Phase 4 trial sponsored by the University Hospital, Basel. This trial evaluates the efficacy of glycosaminoglycan (GAG) replacement therapy, specifically Ialuril Prefill (a combination of sodium hyaluronate and sodium chondroitin sulfate), for the prophylaxis of recurrent urinary tract infections (rUTI). The water is administered via intravesical instillation directly into the bladder, serving as an inert comparator to establish a baseline for the reduction of symptomatic UTI episodes and the subsequent need for antimicrobial therapy. It is manufactured and labeled according to Good Manufacturing Practice (GMP) standards by IBSA Farmaceutici Italia to ensure adequate blinding during the study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sterile purified water.